Position
Squarepoint Ops LLC in Ovid Therapeutics Inc.
Back to the book · All holders of OVID
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $23K$1.63 → $2.22
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 39K | $63.6K | — | — | — | 0.0% |
| Q1 2026 | 198K | $439.5K | $2.22 | $23K | $352.8K | 0.0% |